:2123-9 (November 6) Study Type: POEM Purpose: Does estrogen replacement therapy prevent the diagnosis of AD? Is there any benefit to duration of exposure? Study Duration: 3year assessment trial Patients: 1889 women, 800 had never used HRT, 1066 with any use and 23 with missing data, mean age 74.5 year for women Trial Design: prospective, longitudinal investigation, multistage screening in 1995-97 to diagnose cases of dementia in 5677 elderly residents in Cache County, Utah, 95% gave buccal DNA for APOE genotyping, three years later similar procedures were used to diagnose cases of AD amound the surviving population (4119, 2401 women), those diagnosed went through a battery of test and physician visits for diagnosis and assessment of their disease Cases identified -185 incident cases (123 women, 62 men) -of the 123 women, 88 were probable AD Inclusion: 5677 adult elderly residents of Cache County, Utah Exclusion: none
1.
Are HRT current user 1.08 (0.59-1.91) -mean HRT exposure was 11.6 yrs Compared with nonusers, former users showed significantly reduced risk, if they took the hormones 3-10yrs or greater
3.
Will the results help me? * The risk of AD was cut in half among those using HRT . Benefit is realized only after 10 yrs of use. * The risk was 2.5 fold lower in those women using HRT for more than 10 yrs as compared to men. * 72% of current HRT user were taking unopposed oral estrogen preparation, humm........ * Limitations: -Cache County is well educated, healthy County -are these results generalizable -short follow-up between 2 intake sessions -drug use recall bias * The cases of AD in men was 2.6% (35 cases of 1357 men), similar to those women with any use of HRT.
